“…In contrast to healthy subjects, Parkinson's disease patients responded more slowly and less accurately in the emotional trials than in the control trials, suggesting specific difficulties in processing emotional information. Indeed, faces expressing fear (i.e., negative emotions) were recognized more slowly disturbance has been shown to improve with the combination of STN DBS and levodopa, with this effect being related to the modulation of occipito-temporal activity (Mermillod et al, 2014), which are the regions where we found the highest modulation (N170 source generators shown that Emotional Stroops can be sensitive to the so-called "emotional dilution phenomenon" (Chajut, Schupak, & Algom, 2010;Reynolds & Langerak, 2015), where subject's impaired processing of the emotion decreases the conflict-based difference between congruent and incongruent trials. Thus, by improving emotion recognition and disengagement from the emotion of the face, levodopa would increase susceptibility to both the face and the word, reducing emotional dilution, and thus increasing conflict detection.…”